sur Relief Therapeutics Holding SA (ETR:RLF)
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
MindMaze Therapeutics Holding SA, based in Geneva, announced that Dr. John Krakauer has joined as a strategic advisor. The company aims to expand its growth in the U.S. with his support. Dr. Krakauer, known for his work in motor neuroscience and neurorehabilitation, is the original creator of MindPod®, a precision upper-limb rehabilitation system.
Zach Henderson, CEO of MindMaze Therapeutics, highlighted Dr. Krakauer's foundational work as crucial for their platform. The aim is to reach more patients in need of precision neurotherapeutics across different care settings, including at home.
MindMaze has reported significant improvements through its programs, including enhanced patient mobility and therapy delivery. The company recently established a U.S. headquarters and announced a partnership with Vibra Healthcare.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Relief Therapeutics Holding SA